Nurix Therapeutics, Inc. NRIX Shares Reserved for Future Issuance Under Stock Plans
Shares Reserved for Future Issuance Under Stock Plans at other companies
Other financials
Where this comes from
Reported directly by Nurix Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CommonStockCapitalSharesReservedForFutureIssuance.
The official record: Nurix Therapeutics, Inc.’s 10-Q, filed April 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Nurix Therapeutics, Inc.'s shares reserved for future issuance under stock plans.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Nurix Therapeutics, Inc.'s shares reserved for future issuance under stock plans?
- Nurix Therapeutics, Inc. (NRIX) reported shares reserved for future issuance under stock plans of 31.1M in Q4 2025.
- How has Nurix Therapeutics, Inc.'s shares reserved for future issuance under stock plans changed year-over-year?
- Nurix Therapeutics, Inc.'s shares reserved for future issuance under stock plans increased by 12.3% year-over-year, from 27.7M to 31.1M.
- What is the long-term trend for Nurix Therapeutics, Inc.'s shares reserved for future issuance under stock plans?
- Over 3 years (2022 to 2025), Nurix Therapeutics, Inc.'s shares reserved for future issuance under stock plans has grown at a 13.9% compound annual growth rate (CAGR), from 18M to 26.6M.
- What does shares reserved for future issuance under stock plans mean?
- This represents the total number of common shares authorized and set aside for future issuance to employees and directors under equity compensation plans. It provides insight into the potential future dilution of existing shareholders. Investors monitor this to assess the firm's long-term incentive structure.